Austin Institute for Clinical Research

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Austin Institute for Clinical Research sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials 1 currently recruiting 5 completed later-stage tilt upper quartile by trial count

Austin Institute for Clinical Research: 6 sponsored US clinical trials, 1 recruiting.

Austin Institute for Clinical Research sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. 3 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Xeroderma, with 1 trials.

Upper-quartile sponsor footprint

Austin Institute for Clinical Research sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

6 total, page 1 of 1

RECRUITING NA

Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production

NCT06376110
COMPLETED Phase 4

Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.

NCT05932732
COMPLETED Phase 4

Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.

NCT06090071
COMPLETED NA

Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults

NCT05908825
COMPLETED Phase 2

Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults

NCT05713760
COMPLETED Phase 3

Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults

NCT05203315

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1
Phase 4 2

Therapeutic Areas

Xeroderma 1
Cutis Laxa Facialis 1
Superficial Basal Cell Carcinoma 1
Acne 1

Where Austin Institute for Clinical Research enrollment is open (later-stage tilt)

1 recruiting of 6 indexed (17% open); 5 completed (83%).

Phase mix: 3 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Xeroderma (1 trial), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Austin Institute for Clinical Research: open-pipeline peers nationwide

Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Austin Institute for Clinical Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 468101214 0%20%40%60%80% Total trials Recruiting share Austin Institute for Clinical Research23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan BranchAdageneAgendiaAkamis BioAngiodynamics
Austin Institute for Clinical Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Austin Institute for Clinical Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Austin Institute for Clinical Research page

6 registered trials is a research-attention snapshot, not an endorsement of Austin Institute for Clinical Research or any single study.

  • 1 of Austin Institute for Clinical Research's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Xeroderma is the condition Austin Institute for Clinical Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Xeroderma trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Austin Institute for Clinical Research pipeline card: 6 registered trials from official public datasets.Report a data error.